In summary, our experiment showed that chemokine CXCL3 is highly expressed in COAD, and its high-level expression is closely associated with several tumor-associated clinicopathological parameters, chemokines, genes, signaling pathways and immunocyte recruitment. The gene discussed is CXCL3; the disease is colon adenocarcinoma.